Kakajangha in Ayurveda: Properties & Everyday Use

What it is

Kakajangha is the Sanskrit name for the root of Peristrophe bicalyculata (Retz.) Nees (syn. Dicliptera bicalyculata), an erect herb in the acanthus family (Acanthaceae). The Ayurvedic Pharmacopoeia of India (Part I, Volume III) monographs it as Kakajangha (Rt.): Peristrophe bicalyculata, with the root as the official part used, a mapping confirmed in a peer-reviewed ethnobotanical survey that lists the species under the name Kakjangha (IJPSR).

Classical properties

• Taste (rasa): bitter (Tikta)
• Qualities (guna): light (Laghu)
• Potency (virya): cooling (Sheeta)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Pitta and Kapha; may increase Vata

Traditional use

A peer-reviewed review of the species reports that traditional healers use P. bicalyculata for skin-related ailments, fever, cough, and colds, likely on account of its anti-inflammatory and antimicrobial properties (Pharmacognosy Journal review, via ScienceDirect). An ethnobotanical survey in Rajasthan records a decoction of the plant taken orally for fever (IJPSR). These are traditional uses, not clinical proof of efficacy.

What research has looked at

Blood sugar and lipids in diabetic rats

A study in the Archives of Basic and Applied Medicine gave methanol leaf extract of P. bicalyculata at several doses to streptozotocin- and alloxan-induced diabetic rats for one week. Treated rats had significantly lower fasting blood glucose than untreated diabetic rats, and at the lowest dose the extract also reduced LDL cholesterol and triglycerides while raising HDL cholesterol and adiponectin (ABAM). This is an animal study in a small sample and does not establish any effect in people.

Diabetic and lipid parameters with whole-plant powder

A separate rat study fed albino rats whole-plant P. bicalyculata powder and reported dose-dependent reductions in blood glucose, with appetite suppression and lethargic movement at the higher doses (MedCrave). Animal findings of this kind are preliminary and cannot be translated into human dosing.

Overall strength of evidence

The evidence base is weak: a few small animal experiments, some published in low-impact journals, with no human trials of kakajangha for any condition. Traditional use for fever and skin complaints should not be read as proof that it works.

Safety notes

Human safety data for kakajangha is minimal. One rat study noted appetite suppression and lethargic movement at higher doses (MedCrave). There are no human safety studies, no established safe dose, and no data for pregnancy or breastfeeding: so safety data is limited, and anyone considering it should talk to a qualified clinician first.

FAQs

What is kakajangha?

Kakajangha is the Ayurvedic name for the root of Peristrophe bicalyculata (Retz.) Nees, an erect herb in the acanthus (Acanthaceae) family. The Ayurvedic Pharmacopoeia of India lists it as an official drug with the root as the part used, and the peer-reviewed survey mapping this identity records the species under the spelling Kakjangha (IJPSR ethnobotanical survey).

What is kakajangha traditionally used for?

Traditional healers use the plant for skin-related ailments, fever, cough, and colds, and ethnobotanical surveys record a decoction taken orally for fever (Pharmacognosy Journal review; IJPSR). The review of the species notes these traditional uses are ascribed to the plant's reputed anti-inflammatory and antimicrobial properties: traditional attributions, not clinically proven effects. These are traditional uses, not proven treatments.

Is there clinical evidence for kakajangha?

No. The available studies are small animal experiments: leaf extract lowered blood sugar and improved lipids in diabetic rats, and whole-plant powder lowered glucose in rats (ABAM; MedCrave). No human trials exist. The studies ran for only about a week, and some appeared in low-impact journals, so they are a weak basis for any health claim.

Is kakajangha safe?

Human safety data is minimal. Animal studies noted appetite suppression and lethargy at higher doses (MedCrave). There is no established safe human dose and no pregnancy safety data, so talk to a qualified clinician before use.

Can kakajangha treat diabetes?

No. Animal studies showing lower blood sugar in diabetic rats do not prove a diabetes treatment. The rat studies tested leaf extracts and whole-plant powder, not approved diabetes therapies, and animal results cannot be translated into human dosing. People with diabetes should not replace or adjust medication based on these preliminary findings; discuss any use with a clinician.

Sources

• Ayurvedic Pharmacopoeia of India, Part I, Vol. III — monograph Kakajangha (Rt.) (Peristrophe bicalyculata, root); identity confirmed in IJPSR ethnobotanical survey
• Peristrophe bicalyculata — a review, Pharmacognosy Journal (2009)
• Antidiabetic activity of Peristrophe bicalyculata leaf extract in streptozotocin- and alloxan-induced diabetic rats — Archives of Basic and Applied Medicine
• Effect of Peristrophe bicalyculata powder on diabetic and lipid parameters in albino rats — IJMBOA

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any herb for a health condition.